e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Tobacco dependence and respiratory disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The influence of smoking on the level of proinflammatory cytokines in patients with COPD
V. Trofimov, L. Dolinina, A. Delieva, O. Galkina (St. Petersburg, Russian Federation)
Source:
Annual Congress 2012 - Tobacco dependence and respiratory disease
Session:
Tobacco dependence and respiratory disease
Session type:
Thematic Poster Session
Number:
1062
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Trofimov, L. Dolinina, A. Delieva, O. Galkina (St. Petersburg, Russian Federation). The influence of smoking on the level of proinflammatory cytokines in patients with COPD. Eur Respir J 2012; 40: Suppl. 56, 1062
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Different changes in plasma concentrations of cytokines and chemokines in patients with COPD associated with smoking and occupational exposures
Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes
Year: 2016
An evaluation of circulating cytokines milieu in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 311s
Year: 2002
Increased inflammatory response and cytokine release (TNF-alpha, IL-8) after environmental tobacco smoke exposure in patients with asthma
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
The effectiveness of N-acetylcysteine in the suppression of pro-inflammatory cytokines in patients with COPD
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics
Source: Eur Respir J 2006; 28: Suppl. 50, 38s
Year: 2006
The levels of proinflammatory cytokines in patients with dust-induced lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 536s
Year: 2001
Factors influencing induced sputum cytokines and VEGF in a population of stable COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 550s
Year: 2006
IL-18 and IL-10 in patients with occupational COPD, depending on the presence or absence of hypertension
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Impact of treatment on a number of BALF inflammatory cells and cytokines concentrations in patients with moderate COPD
Source: Annual Congress 2008 - COPD: from bench to bedside
Year: 2008
Impact of cytokines on endothelium in COPD patients
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Proinflammatory cytokines in induced sputum and COPD phenotype
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
Does obesity affects circulating inflammatory cytokines in asthmatic children?
Source: Annual Congress 2009 - Epidemiology and risk factors of childhood asthma: what every clinician should know
Year: 2009
The effect of smoking on the activity of inflammatory markers in patients with COPD
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
Can leptin and IL-6 influence the nutritional status in COPD patients?
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006
Evaluation of the effect of excess body weight on the level of pro-inflammatory cytokines in patients with asthma-COPD overlap.
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020
Cigarette smoking induced elevated CXCL5 levels in BALF and plasma of patients with COPD
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018
The pro-resoliving lipid mediator lipoxin A4 inversely correlates with proinflammatory chemokines and identifies a subgroup of asthma patients with disease progression
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020
The proinflammatory cytokine is important in determining the severity of asthma enhancing the inflammatory process
Source: Eur Respir J 2004; 24: Suppl. 48, 592s
Year: 2004
Leptin and inflammatory cytokines during COPD exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 252s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept